Date: 23.7.2018
Summary:
A German university offers lansoprazole sulfide as a drug to treat tuberculosis. The new drug is also active against multidrug-resistant tuberculosis. It has been tested in-vitro and in-vivo. Partners from the pharmaceutical industry are sought for licensing agreements.
Reference: TODE20180328002
Country: Germany
Submitted: 23. 7. 2018
Keywords
Technology: Pharmaceutics, Gene - DNA Therapy, Pharmaceutical Products / Drugs
Market: Therapeutic, Pharmaceuticals/fine chemicals
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Africa Biotech - Biotechnology and African Agriculture news
Researchers uncover key biomolecule involved in whooping cough infection
Mussel-inspired adhesive builds a bond between implants and bones